InsidersTradesSigma
基于 3 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the detailed record of transactions filed by Wambeke David J.. Officer active across 2 companies, notably DiaMedica Therapeutics Inc.. Aggregated, 5 filings have been logged. Split: 5 buys · 0 sell. Total volume traded: €1.5m. History available since 10 April 2023. The latest transaction was disclosed on 27 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Wambeke David J. is a declarant associated with DiaMedica Therapeutics Inc. and NEUROONE MEDICAL TECHNOLOGIES Corp, where he is Chief Business Officer. He has 5 filings in total, and across the recent filings observed from 2023-04-11 to 2026-09-08, buys total 1497668 EUR and sells are 0 EUR, with transactions of the Acquisition type.